RGEN Financial Facts
Product revenue: 24.68MNet (loss) income: 1.16M
See Full Income Statement
Total current assets: 219.83M
Accrued liabilities: 15.13M
See Full Balance Sheet
Repligen Corporation (RGEN) Earnings
|
Expand Research on RGEN
| Next EPS Date | 7/29/26 *Est. | EPS Growth Rate | -100.0% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | +6.8% | Revenue Growth Rate | -100.0% *Last Qtr. |
| Average % Move 1-Wk after EPS | -4.8% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
5/5/26  |
Q126 | N/A | $0.39 | N/A | N/A | $191.94M | = | N/A | N/A | ||
| 2/24/26 | Q425 | $0.49 | $0.44 | +$0.05 | $197.91M | $192.89M | = |  | | Details | |
| 10/28/25 | Q325 | $0.46 | $0.42 | +$0.04 | $189M | $181.78M | = | | | Details | |
| 7/29/25 | Q225 | $0.37 | $0.39 | -$0.02 | $182M | $175.35M | = | | | Details | |
| 4/29/25 | Q125 | $0.39 | $0.35 | +$0.04 | $169M | $163.4M | = | | | Details | |
| 2/20/25 | Q424 | $0.44 | $0.41 | +$0.03 | $168M | $167.67M | = | | | Details | |
| 11/12/24 | Q324 | $0.43 | $0.33 | +$0.10 | $155M | $153.22M | = | | | Details | |
| 10/29/24 | Q324 | N/A | $0.33 | N/A | N/A | $153.22M | = | N/A | N/A |
